Having a “plane outfit” has died out and been replaced by a mound of joggers and compression socks. But it’s not hard to add a little luxury to your travel look ...

EO-3021 is a Claudin 18.2 antibody-drug conjugate (ADC), which Elevation Oncology was developing for the treatment of advanced, unresectable or metastatic gastric and gastroesophageal junction ...

Elevation Oncology discontinues EO-3021 development due to insufficient efficacy in phase 1 trial, despite favorable safety profile. EO-3021 trial showed a 22.2% objective response rate and 72.2% ...

Donations to The Gabber Newspaper go through the Florida Press Foundation, a 501(c)(3) tax-exempt organization with its principal place of business in Florida. The Florida Press Foundation is ...

ROBYN M DENHOLM, a director at $TSLA, sold 3,021 shares of the company on 03-03-2025 for an estimated $899,602. We received data on the trade from a recent SEC filing ...